Strategy & Due Diligence in Pharma Business Development
Pharma growth depends on smarter BD decisions. This article outlines a clear framework to evaluate external opportunities before committing to formal diligence.
Pharma growth depends on smarter BD decisions. This article outlines a clear framework to evaluate external opportunities before committing to formal diligence.
Pharma’s business development and licensing (BD&L) teams are at the forefront of identifying new science to support their company’s future.